It is vital to have a robust controlled substance monitoring program to promptly identify and mitigate drug diversion.
Aakash Gandhi, PharmD
Advertisement
Articles by Aakash Gandhi, PharmD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Pharmacy Times
1
States Push Forward on Insurance Mandates for GLP-1 and Obesity Treatments
2
Clinical Data Support Use of Low-Carbon Version of Albuterol Metered Dose Inhaler for Asthma
3
FDA Expands Approval of Sotatercept-Csrk for Pulmonary Arterial Hypertension
4
Expert Insights on Key Data from IMS 2025
5
